Literature DB >> 1676319

Open access clinic providing HIV-I antibody results on day of testing: the first twelve months.

S B Squire1, J Elford, R Bor, G Tilsed, H Salt, E K Bagdades, G Janossy, P D Griffiths, M A Johnson.   

Abstract

OBJECTIVES: To determine the sociodemographic profile, risk category, and prevalence of HIV-I infection among people attending a clinic providing counselling, medical advice, and results of HIV-I antibody testing on the day of consultation; to determine the stage of infection and peripheral blood CD4 cell count among attenders with detectable HIV-I antibodies.
DESIGN: Analysis of prospectively collected data for the 12 months from March 1989.
SETTING: Same day testing clinic run by the HIV/AIDS team at an urban teaching hospital. PATIENTS: 561 consecutive people choosing to attend and proceeding to HIV-I testing.
RESULTS: The demand for the service caused it to run to capacity within six months. The median age of those attending was 28 years and 65% (364 patients) were male. The overall prevalence of HIV-I infection was 3.9% (22 patients). The greatest prevalence was in men reporting their primary risk as homosexual contact (11.9%, 13/109). The median CD4 cell count in the 22 patients who had detectable HIV-I antibodies was 0.31 x 10(9) cells/l (normal range 0.5 x 10(9)/l to 1.2 x 10(9)/l). Twenty of these patients were asymptomatic (Centers for Disease Control stages II or III), 14 had CD4 cell counts below 0.5 x 10(9)/l.
CONCLUSIONS: There is a recognisable demand for a service providing rapid results of HIV-I antibody testing in this setting. The overall seroprevalence of 3.9% is comparable with the 5.8% reported from freestanding clinics in the United States. Most patients with HIV-I antibodies detected in this way are asymptomatic but could benefit from early medical intervention because of low CD4 cell counts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676319      PMCID: PMC1670043          DOI: 10.1136/bmj.302.6789.1383

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  12 in total

Review 1.  Natural history of HIV infection.

Authors:  A R Moss; P Bacchetti
Journal:  AIDS       Date:  1989-02       Impact factor: 4.177

2.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

3.  HIV infection: increase in public awareness and anxiety.

Authors:  C Sonnex; A Petherick; M W Adler; D Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

4.  HIV testing: changing trends at a clinic for sexually transmitted diseases in London.

Authors:  E J Beck; D G Cunningham; V W Moss; J R Harris; A J Pinching; D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

5.  Serial CD4 lymphocyte counts and development of AIDS.

Authors:  A N Phillips; C A Lee; J Elford; G Janossy; A Timms; M Bofill; P B Kernoff
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

6.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

Authors:  H Masur; F P Ognibene; R Yarchoan; J H Shelhamer; B F Baird; W Travis; A F Suffredini; L Deyton; J A Kovacs; J Falloon
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

Review 7.  Human immunodeficiency virus test evaluation, performance, and use. Proposals to make good tests better.

Authors:  J S Schwartz; P E Dans; B P Kinosian
Journal:  JAMA       Date:  1988-05-06       Impact factor: 56.272

8.  Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.

Authors:  M A Fischl; G M Dickinson; L La Voie
Journal:  JAMA       Date:  1988-02-26       Impact factor: 56.272

Review 9.  Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms.

Authors:  B Lo; R L Steinbrook; M Cooke; T J Coates; E J Walters; S B Hulley
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  11 in total

1.  Pre-HIV antibody testing--too much fuss?

Authors:  R Miller; R Bor
Journal:  Genitourin Med       Date:  1992-02

2.  Same day testing for HIV.

Authors: 
Journal:  BMJ       Date:  1991-07-13

3.  Same day testing for HIV.

Authors:  C J Ronalds; F Ward; L Streether; J Anderson; A Murray; D J Jeffries; W Nelson
Journal:  BMJ       Date:  1991-08-03

4.  Counselling patients before an HIV test.

Authors:  R Bor; R Miller; M Johnson
Journal:  BMJ       Date:  1991-12-07

5.  HIV pre-test discussion.

Authors:  R Miller; M Lipman
Journal:  BMJ       Date:  1996-07-20

6.  Screening for sexually transmitted diseases in an HIV testing clinic: uptake and prevalence.

Authors:  N A Smith; E M Carlin; F C Boag
Journal:  Genitourin Med       Date:  1997-06

7.  Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests.

Authors:  P G Farnham; R D Gorsky; D R Holtgrave; W K Jones; M E Guinan
Journal:  Public Health Rep       Date:  1996 Jan-Feb       Impact factor: 2.792

8.  New clinics for HIV testing. Improve public access.

Authors:  N J Beeching; F N Nye; M Prior; C Morrison; S M Ruben; K J Mutton
Journal:  BMJ       Date:  1993-05-01

Review 9.  Rapid HIV testing: a review of the literature and implications for the clinician.

Authors:  Carlos Franco-Paredes; Ildefonso Tellez; Carlos del Rio
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

10.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.